Encompass Health (EHC) Stock Overview
Operates inpatient rehabilitation hospitals in the United States and Puerto Rico. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EHC Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Encompass Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$100.30 |
| 52 Week High | US$127.99 |
| 52 Week Low | US$92.53 |
| Beta | 0.56 |
| 1 Month Change | -7.98% |
| 3 Month Change | -6.26% |
| 1 Year Change | 7.07% |
| 3 Year Change | 89.35% |
| 5 Year Change | 24.88% |
| Change since IPO | 1,788.00% |
Recent News & Updates
Recent updates
Encompass Health: Structural Advantages In A Fragmented Market
Feb 10Encompass Health Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 07
A Look At The Intrinsic Value Of Encompass Health Corporation (NYSE:EHC)
Jul 20Encompass Health Corporation's (NYSE:EHC) Share Price Could Signal Some Risk
Jun 11Here's Why We Think Encompass Health (NYSE:EHC) Is Well Worth Watching
May 21Here's Why Encompass Health Corporation's (NYSE:EHC) CEO May Deserve A Raise
Apr 25We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Mar 19
Expanding Healthcare Services And Decisive Partnerships Propel Revenue Growth And Shareholder Value
Expanding service demand through significant growth in neurological and stroke treatment areas suggests potential for future revenue increases.Shareholder Returns
| EHC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -6.8% | -3.8% | -2.3% |
| 1Y | 7.1% | -20.4% | 20.4% |
Return vs Industry: EHC exceeded the US Healthcare industry which returned -18.7% over the past year.
Return vs Market: EHC underperformed the US Market which returned 21.2% over the past year.
Price Volatility
| EHC volatility | |
|---|---|
| EHC Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: EHC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: EHC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 26,272 | Mark Tarr | www.encompasshealth.com |
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients.
Encompass Health Corporation Fundamentals Summary
| EHC fundamental statistics | |
|---|---|
| Market cap | US$10.00b |
| Earnings (TTM) | US$565.70m |
| Revenue (TTM) | US$5.94b |
Is EHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EHC income statement (TTM) | |
|---|---|
| Revenue | US$5.94b |
| Cost of Revenue | US$3.37b |
| Gross Profit | US$2.56b |
| Other Expenses | US$2.00b |
| Earnings | US$565.70m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.69 |
| Gross Margin | 43.22% |
| Net Profit Margin | 9.53% |
| Debt/Equity Ratio | 66.2% |
How did EHC perform over the long term?
See historical performance and comparisonDividends
Does EHC pay a reliable dividends?
See EHC dividend history and benchmarks| Encompass Health dividend dates | |
|---|---|
| Ex Dividend Date | Apr 01 2026 |
| Dividend Pay Date | Apr 15 2026 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 32 days |
Does EHC pay a reliable dividends?
See EHC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 18:57 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Encompass Health Corporation is covered by 27 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Adam Feinstein | Barclays |
| Andrew Mok | Barclays |